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Abstract
Background
Most people with dementia do not receive timely diagnosis, preventing them from making
informed plans about their future and accessing services. Many countries have a policy to
increase timely diagnosis, but trials aimed at changing general practitioner (GP) practice
have been unsuccessful. We aimed to assess whether a GP’s personal letter, with an evi-
dence-based leaflet about overcoming barriers to accessing help for memory problems—
aimed at empowering patients and families—increases timely dementia diagnosis and
patient presentation to general practice.
Methods and finding
Multicentre, cluster-randomised controlled trial with raters masked to an online computer-
generated randomisation system assessing 1 y outcome. We recruited 22 general practices
(August 2013–September 2014) and 13 corresponding secondary care memory services in
London, Hertfordshire, and Essex, United Kingdom. Eligible patients were aged70 y, with-
out a known diagnosis of dementia, living in their own homes. There were 6,387 such
patients in 11 intervention practices and 8,171 in the control practices. The primary outcome
was cognitive severity on Mini Mental State Examination (MMSE). Main secondary out-
comes were proportion of patients consulting their GP with suspected memory disorders
and proportion of those referred to memory clinics. There was no between-group difference
in cognitive severity at diagnosis (99 intervention, mean MMSE = 22.04, 95% confidence
intervals (CIs) = 20.95 to 23.13; 124 control, mean MMSE = 22.59, 95% CI = 21.58 to 23.6;
p = 0.48). GP consultations with patients with suspected memory disorders increased in
intervention versus control group (odds ratio = 1.41; 95% CI = 1.28, 1.54). There was no
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between-group difference in the proportions of patients referred to memory clinics (166,
2.5%; 220, 2.7%; p = .077 respectively). The study was limited as we do not know whether
the additional patients presenting to GPs had objective as well as subjective memory prob-
lems and therefore should have been referred. In addition, we aimed to empower patients
but did not do anything to change GP practice.
Conclusions
Our intervention to access timely dementia diagnosis resulted in more patients presenting to
GPs with memory problems, but no diagnoses increase. We are uncertain as to the reason
for this and do not know whether empowering the public and targeting GPs would have
resulted in a successful intervention. Future interventions should be targeted at both
patients and GPs.
Trial registration
Current Controlled Trials ISRCTN19216873
Author summary
Why was this study done?
• Early (timely) diagnosis of dementia allows people to plan for the future, receive symp-
tomatic treatment, access social and voluntary care, helps family carers, reduces crises,
and delays care home entry for people with dementia with little negative effects.
• Many countries have a policy to increase timely diagnosis, but trials aimed at changing
general practitioner (GP) behaviour have been unsuccessful.
• We aimed to assess whether empowering patients and their families by sending patients
aged 70 or over without a known diagnosis of dementia the intervention (a GP’s per-
sonal letter, with an evidence-based leaflet about overcoming barriers to accessing help
for memory problems) increases earlier dementia diagnosis through GPs referral to
memory clinics compared to continuing usual practice alone (control).
What did the researchers do and find?
• GP practices were randomly allocated to send patients a personally signed letter and
information leaflets (11 practices, 6,387 patients) or usual care (11 practices, 8,171
patients).
• Our intervention had no effect at increasing timely or overall diagnosis as the memory
scores (measured by Mini Mental State Examination) of people in the intervention and
the control group (22.04 versus 22.59) at diagnosis were not statistically, nor substan-
tially, different.
• There was a significant increase in the proportion of patients in the intervention prac-
tices compared to control practice consulting their GPs with suspected memory
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difficulties (odds ratio = 1.4; 95% CI = 1.28, 1.54) but no difference in the proportion of
all practice patients referred to memory services (intervention group = 2.5% versus con-
trol group = 2.7%).
What do these findings mean?
• Empowering patients using a GP’s personal letter plus evidence-based leaflet is not by
itself enough to improve timely access to dementia services.
• Our study was limited, as we do not know whether these extra patients were more con-
cerned, but without memory problems “worried well,” or whether they had memory
problems which were not recognised by their GP.
• Future interventions could target both public and practitioners, concentrating on earlier
diagnosis benefits.
Introduction
The number of people with dementia is increasing worldwide as the population ages [1].
Across developed countries, many people with dementia never receive a diagnosis, while oth-
ers receive one late in the illness [2]. Our systematic review of interventions to increase the
rates of dementia diagnosis reports no clearly successful intervention; although educating gen-
eral practitioners (GPs) increased their ability to diagnose dementia, this approach did not
result in increased diagnostic rates [3]. Currently, the dementias are incurable, but early diag-
nosis allows people to plan for the future [4], receive treatment to reduce cognitive and neuro-
psychiatric symptoms [5,6], and access social and voluntary care. Early diagnosis also helps
family carers [7], reduces crises, and delays care home entry [8] for people with dementia with
little negative effects [9].
Family carers report difficulty in obtaining a diagnosis of dementia for their relative, which
can take several years, with the delay causing increased anxiety and carer burden [10–12].
Families find that some relatives with memory problems are reluctant to consult their GP
about it and deny problems when seen [11,13]. Barriers to seeking help or diagnosis include
fear of the diagnosis, concerns about stigma, GP disinclination to make this diagnosis, negative
responses from other family members, normalisation of symptoms, and a lack of awareness
about the signs of dementia [13–16].
Our systematic review of interventions to increase the rates of dementia diagnosis reports
no clearly successful intervention; although educating GPs increased their ability to diagnose
dementia, this did not result in increased diagnostic rates [3]. Previous interventions have nei-
ther specifically targeted and tried to empower older people nor used the relationship with
GPs to address barriers to diagnosis other than symptom recognition. This has helped in other
fields; for example, GP personal letters with information leaflets changed patient’s behaviour
regarding diagnosis of bowel cancer, leading to increase in uptake of diagnostic procedures
[17].
We therefore aimed to facilitate patients and families to present to their GP and gain a
timely diagnosis of dementia (as evaluated through cognitive severity at presentation), through
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a personalised letter and evidence-based leaflet [11] sent directly to patients registered with
general practices and to evaluate this in a randomised controlled trial (RCT).
Methods
Study design
Multicentre, parallel group, cluster RCT. We recruited general practices in southeast England
(north and east London, Hertfordshire, and Essex). The practices were diverse in socioeco-
nomic status and ethnic composition and ranged from inner-city to rural locations. The corre-
sponding memory services were in Camden and Islington NHS Foundation Trust, North East
London NHS Foundation Trust, East London NHS Foundation Trust, Barnet, Enfield and
Haringey Mental Health Trust, and Hertfordshire NHS Partnership Foundation Trust. We
obtained written ethics approval for the study from National Research Ethics Service (NRES)
Committee London, Queen Square for the trial (ID: 13\LO\0996). Research and development
permission was obtained from local trusts and clinical commissioning group areas in which
the GP practices were located. The protocol is available (S1 Text) at http://www.isrctn.com/
ISRCTN19216873 and the CONSORT statement in S2 Text.
Patients
We included registered patients 70 y or older within general practices. We excluded people
known to have dementia or who lived in care homes. All participating GP practices and mem-
ory clinics gave written informed consent.
Randomisation and masking
The trial statistician (GB) set up an online computer-generated randomisation system, allocat-
ing participants to intervention or usual care in ratio 1:1 stratified by geographical location
(London, Essex, Hertfordshire) using random permuted blocks. He was not involved in the
remainder of the trial until analysis. Independent raters, masked to randomisation status, col-
lected data about patients referred from participating GP practices to memory services, both
for the year before and the year after the study. We masked memory services but could not
mask GP practices or their patients who received a leaflet. Masked raters collected information
from Morbidity Information Query and Export Syntax (MIQUEST), a Department of Health
interface for anonymised data extraction from GP practices [18].
Procedures
Recruitment and follow-up. We recruited GP practices and the corresponding memory
services to which GP practices referred and collected anonymised baseline and follow-up data.
Cluster Caldicott guardians gave consent to collect anonymised data and for the RCT [19] as
gatekeepers of patient groups when consent must be given for a whole cluster.
Intervention. The original leaflet was developed from a study with family carers about
barriers and facilitators to seeking help for memory problems [11]. We used the UK Medical
Research Council (MRC) complex intervention development recommendations [20] to
improve the intervention through consultation with the Alzheimer’s Society GP reference
group, family carers, people with mild cognitive impairment (MCI), and dementia experts.
We refined the text content, layout, colour, illustrations, usability, and acceptability. We then
used a professional designer. The leaflet contains information about overcoming common bar-
riers to accessing dementia diagnosis and care if people are concerned about themselves or a
relative. It covers how to persuade someone to go to the doctor to seek help if there are
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memory worries, what information to give to the GP, how to be referred to specialist services,
confidentiality, overcoming refusal of help, information available for patients and families
about dementia, and what to do if things are not working.
We developed a personal letter signed by their GP to the “at risk” population (people70 y
living at home without a known diagnosis of dementia) to accompany the leaflet, following
similar consultation. The letter was addressed to the individual patient and explained the leaf-
let was about how to get help for themselves or someone else they knew with memory prob-
lems. It outlined potential symptoms, stressed these should have persisted for over 3 mo, that
help is available, and they should contact their GP if worried about themselves or a relative.
The GPs did not change the main text of the letter, but they provided personalised contact
details. Leaflet and letter are in S3 and S4 Text and the leaflet can be found at http://www.ucl.
ac.uk/psychiatry/research/olderpeople.
Treatment as usual. The control group received usual care in line with standard current
practice. Patients presented to the GP as they wished and GPs assessed and considered a mem-
ory service referral for diagnostic assessment. There are current clinical guidelines for demen-
tia care [12].
Assessments. We collected the following information from memory services for the year
before and after baseline:
1. Sociodemographic data: sex, age, ethnic status according to census, marital status,
education.
2. Cognitive score at diagnosis; measured by the Mini Mental State Examination [21]
(MMSE) or the Addenbrooke’s Cognitive Examination (ACE-R or ACE-III) [22,23] of
people who received a diagnosis of dementia or MCI.
3. The number of patients referred to memory services from intervention and control
practices.
4. The number of memory services appointments offered and people attending for diagnos-
tic assessment.
Possible adverse events:
5. The number of people referred who were assessed as not having dementia or MCI.
6. We asked at the commencement of the study for every GP practice to inform us, and then
checked after, about inappropriate presentations, patient distress, and whether the inter-
vention led to unacceptable numbers of presentations.
We collected the following information from GPs for the year before and after baseline:
1. We recorded the number of eligible patients in each practice.
2. Memory, cognitive, or dementia-related examinations. We used MIQUEST (a data extrac-
tion tool, which allows the anonymous extraction of patient information about the content
of every clinical consultation from the different brands of GP computerised medical record
systems) to extract data from GP notes. We prespecified codes encompassing cognitive
examination or a comment about memory, cognitive, or dementia screening, assessment,
testing, observation, level or reviewing. We collected whether each patient aged over 50-y-
old had one or more consultation about their memory over the year after randomisation.
As the data were anonymised, we could not link it to patients referred to memory clinics.
Encouraging prompt referral to memory clinics for diagnosis of dementia
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Outcomes
Our primary outcome was to determine if our intervention led to people with dementia or
MCI presenting earlier to specialist dementia services, i.e., with higher cognitive scores at diag-
nosis compared with usual care over 12 mo.
The secondary outcomes compared the effect of the intervention versus treatment as usual
(TAU) on:
1. Number of eligible patients presenting with cognitive problems to their GP.
2. Rate of GP referral of patients with a suspected diagnosis of dementia to memory
services.
3. The proportion of eligible patients who were referred to a memory clinic.
4. The number of patients subsequently diagnosed with a cognitive disorder (dementia or
MCI).
5. The number of memory service appointments offered to those referred.
6. The costs of implementing the intervention.
Possible harm:
7. GP referral of those who do not have dementia or MCI (as the intervention may have
caused worry in those who are well).
8. GP practice report of negative comments from patients or relatives sent the interventions.
Patient involvement
Family carers were interviewed for the original content of the leaflet [11] and then family car-
ers, people with cognitive disorder, and GPs from the Alzheimer’s Society were asked about
leaflet redesign. Members of the Alzheimer’s Society Research Network contributed to the
design of the study, monitored the conduct of the study, and were on the steering group.
Statistical analysis
Power calculation. This sample size was based on the average GP-registered patient pop-
ulation of 2,000, of whom 260 (13%) were aged 70 y or older [24]. An audit of the referral rates
and MMSE scores of people with dementia presenting to one memory service found the mean
number of referrals was 11 patients/ practice/y, with a mean MMSE = 19.5 (standard devia-
tion, SD = 6.1). A difference of three points in MMSE has been reported as clinically signifi-
cant [25]. We required 71 undiagnosed people with dementia to present to memory clinics in
each group in order to detect a difference of three points, with 90% power at a 5% significance
level. To account for clustering within each GP practice, we inflated the sample based on a pro-
jected intracluster correlation (ICC) of 0.03 [26]. Based on these calculations, we required a
sample size of 93 patients referred in each group. We allowed for 18% attrition of referred
patients who did not have the full memory clinic assessment, thus inflating the sample size to
114/group. We planned to recruit 11 GP practices to each arm of the study using the estimate
of 11 patients referred per practice per year.
Changes to trial outcome after the trial commenced. The MMSE was the measure of
cognition we had envisaged being available for most patients. However, possibly because of a
change in charging for the use of the MMSE [27], many memory services were using other
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cognitive measures, most commonly the 100 point ACE-R and ACE-III. We decided before
we began the analysis to include patients with MMSE scores and to make a complete dataset of
MMSE for those without MMSE scores but with ACE scores by imputing the missing data.
We employed multiple imputation after using data on the latter to estimate the missing MMSE
scores. We ran a regression model on the 221 patients across both study arms who had both
MMSE and ACE. This included some people who were excluded from the analysis of out-
comes, as they were already known to have dementia.
The MMSE score was the response variable and the ACE score the predictor. The coeffi-
cients of the intercept and the ACE score were statistically significant and consistent with a
recent study of established dementia [28]. This latter model assumes absence of the MMSE is
explained entirely by the ACE value, which may be too simplistic. We therefore used multiple
imputation by chained equations (MICE) [29] and controlled for other potentially relevant
factors: sex, age, marital status, living condition, education, area-level index of multiple depri-
vation, and a random effect by practice. Following standard practice, we imputed five complete
datasets and analysed them separately, pooling the results using Rubin’s rule [30] and using
these estimates for the remaining analysis. We then converted the ACE scores using the ACE
and MMSE as a single outcome score (called “combined MMSE” in this paper).
Analysis. There was no study data monitoring committee. We reported new referrals data
of those with cognitive disorders by randomisation group. We compared the mean combined
MMSE from each group, using t tests to assess statistical differences controlling for age, educa-
tion, and sex.
We used hierarchical multivariate regression analysis to account for patient clustering and
to adjust for baseline differences in outcomes. We used multiple linear regression to identify
demographic predictors of combined MMSE at presentation: sex, age, education, and ethnic-
ity. Random effects were included to account for the clustering effect of GP practices. We
adjusted for potential missing data using multiple imputations. We also repeated this in a sen-
sitivity analysis of only those patients who had MMSE scores.
We performed chi-square tests comparing the proportion of referrals to memory services
between trial arms and between the year before and the year after the intervention.
We compared GP contacts from MIQUEST [18] practice records using a regression model
and accounting for recording of memory assessments the year before baseline.
We calculated the costs of the intervention based on the costs of leaflet printing, of identify-
ing patients to send it to, and of postage and packing.
Post hoc analysis. As the study covered years in which increasing the timely diagnosis of
dementia had become a national priority, we performed a post hoc analysis of change in num-
bers of those referred, diagnosis of cognitive disorder, and stage of referral (cognitive score) in
both groups over the year before and after the intervention.
All statistical analyses followed a predefined analysis plan and were carried out using the
freely available statistical software R, version 3.2.0.
Results
We approached 43 practices, and 22 were randomised. The consolidated reporting of trials
(CONSORT: Fig 1) diagram shows practices’ and patients’ progress through the trial. We
recruited GP practices between 16th August 2013 and 14th December 2013 and the corre-
sponding memory services between 11th December 2013 and 23rd September 2014. All mem-
ory services linked to the practices included in the study were recruited. We collected follow-
up data from participating memory services between 16th April 2014 and 2nd October 2015.
We stopped the trial once we had recruited the practices and follow-up was completed. Table 1
Encouraging prompt referral to memory clinics for diagnosis of dementia
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Fig 1. CONSORT flow diagram.
doi:10.1371/journal.pmed.1002252.g001
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shows the baseline characteristics of those presenting to memory clinics with a suspected diag-
nosis of dementia. As expected, the majority of patients were female and the mean age was
around 80-y-old.
There were 223 people with scores from the combined Mini Mental State Examination
(MMSE) at follow-up (99/109; 90.8% in the intervention and 124/157; 79.0% control), of
whom 173 had had an MMSE; 83 intervention and 90 control. The intracluster correlation
(ICC) for the GP practices for the primary outcome was 0.0024. Three hundred and eighty-six
patients were referred but because of death, refusal, and moving, 62 were never fully assessed.
Two hundred and sixty-six out of three hundred and twenty-four people (82.15%) who pre-
sented to memory clinics from the practices and were fully assessed received a diagnosis of
cognitive disorder.
Overall, we analysed 223/266 (83.8%) diagnosed patients. The raw scores on MMSE and
Addenbrooke’s Cognitive Examination (ACE) in each group are in Table 2. There was no
effect of the intervention on cognitive severity at diagnosis (intervention group mean com-
bined MMSE score = 22.04, 95% CI = 20.95 to 23.13, standard deviation (SD) = 5.54; control
group mean combined MMSE = 22.59, 95% CI = 21.58 to 23.6, SD = 5.73; p = 0.48).
Similarly, in a sensitivity analysis, we found no evidence of an effect of the intervention on
the mean MMSE at presentation between the 83 patients in the intervention (mean MMSE
score: 22.4, SD: 5.5) and 90 in the control group (mean MMSE score: 22.3, SD: 6.3) with a
valid MMSE (p = 0.91).
Both intervention and control groups had more presentations to the GP for cognitive prob-
lems in the year after than the year before baseline (see Table 3 for secondary outcomes. There
were more consultations with people with a suspected memory disorder in the GP practices in
the intervention compared to the control adjusted for the initial rate of GP recording. GPs
Table 1. Demographic characteristics of those presenting to memory clinics with suspected dementia.
Demographic Intervention Control All
Gender (%) Male 76 (45.8) n = 166 84 (38.2) n = 220 160 (41.5) n = 386
Age n = 386 Mean; SD (range) 80.52; 8.97 (47–97) n = 166 79.78; 8.60 (51–97) n = 220 80.10; 8.76 (47–97)
Ethnicity (%) n = 302 White 85 (76.6) 173 (90.6) 258 (85.4)
British other 26 (23.4) 18 (9.4) 44 (14.6)
Marital status (%) n = 350 Currently not living with partner/married 77 (52.7) 98(48.3) 175 (50)
Currently married/living with partner 70 (47.6) 105 (51.7) 175 (50)
Living situation (%) n = 353 Living alone 76 (49.0) 84 (42.4) 160 (45.3)
Living with other 79 (50.1) 114 (57.6) 193 (54.7)
Level of education (%) n = 262 No education 2 (1.9) 2 (1.3) 4 (1.5
Primary 2 (1.9) 2 (1.3) 4 (1.5)
Secondary 82 (76.6) 107 (69.0) 189 (72.1)
Post–secondary education 21 (19.6) 44 (28.4) 65 (24.8)
SD, standard deviation
doi:10.1371/journal.pmed.1002252.t001
Table 2. MMSE and ACE scores.
Control Intervention
N Mean SD range N Mean SD range
MMSE scores 90 22.3 6.3 0–30 83 22.4 5.5 0–29
ACE 83 69.2 16.2 30–96 67 65.5 16.5 22–92
doi:10.1371/journal.pmed.1002252.t002
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who had recorded seeing more patients with memory problems in the year before baseline also
recorded seeing more in the year after. Both intervention and control groups present more to
their GP with suspected memory problems although this increase is greater in those in the
intervention than the control group (odds ratio [OR] = 1.41, CI: 1.28–1.54). GPs reacted to the
increased numbers presenting to them by referring a lesser proportion than in the year before
the intervention, and the decrease is more marked in the intervention group (chance of being
referred in intervention group versus control OR = 0.70, CI: 0.57–0.85). However, as more
patients presented to their GP, the proportion of eligible patients (those aged over 70) referred
to a memory clinic increased in both groups and there was no significant difference between
the two groups (OR = 1.08; CI: 0.91–1.27).
There was no between-group difference in the rate of referral in the year after the interven-
tion of eligible patients in the practices (2.5% and 2.7% intervention and control group, respec-
tively). Nor was there a between-group difference in referral rate of those subsequently
diagnosed with either dementia or mild cognitive impairment (MCI; 113: 85.6% and 161:
83.9%; p = 0.79 for intervention and control group, respectively). Both groups had significant
increase in diagnosis rates of cognitive disorder in memory clinics between the year before
baseline and follow-up: the intervention arm increased from 16.2% to 22.6%; and for control
from 12.0% to 23.0%, overall p< 0.0001.
There was no difference in the rate of memory services appointments of eligible patients
offered in the year after the intervention between the intervention and the control group
(160/6,387 [2.5%] and 206/8,171 [2.5%], respectively [p = 0.99]).
Table 3. Secondary outcomes for intervention groups versus control in the year after intervention.
Intervention Control Odds ratio
Number/eligible
population, %
Number/eligible
population, %
*Intervention versus
control
Percentage of eligible patients presenting with cognitive problems to their
GP (patients aged70-y-old)
Preintervention 293/6,387
(4.6%)
Preintervention 223/8,171
(2.8%)
OR = 1.41, CI: 1.28–
1.54
Postintervention 699/
6,387 (10.9%);
Postintervention 699/
8,171 (8.55%)
Patients referred to memory clinics/number of patients presenting to their
GPs with memory problems (controlling for baseline patients aged70 y
Preintervention 106/293
(36.18%);
Preintervention 104/223
(46.64%)
OR = 0.70, CI: 0.57–
0.85
Postintervention 166/699
(23.75%);
Postintervention 220/699
(31.47%)
Patients referred to memory clinics/number eligible patients in the group
(controlling for baseline)
Preintervention 106/6,387
(1.66%);
Preintervention 104/8,171
(1.27%)
OR = 1.08, CI: 0.91–
1.27
Postintervention 166/
6,387 (2.6%);
Postintervention 220/8171
(2.69%)
The number of patients subsequently diagnosed with a cognitive disorder
of those assessed (dementia or MCI).
109/132 (82.6%)
• 90 dementias
• 19 MCI
157/192(81.8%)
• 108 dementia
• 49 MCI
Number of memory service appointments offered to those referred 160/166 (96.4%) 206/220 (93.6%)
GP referral of those who do not have dementia or MCI 23 (34 more not
completely assessed)
35 (28 more not
completely assessed)
The costs of implementing the intervention. £2.16 £0.00
GP practice report of negative comments from patients or relatives sent
the interventions
0 0
*Controlled for baseline
MCI, mild cognitive impairment
doi:10.1371/journal.pmed.1002252.t003
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Both intervention and control groups had a significant increase in referrals to memory ser-
vices between the year before baseline and the year after. The intervention arm increased from
106 (1.65%) to 166 (2.6%), p< 0.0003; and for control from 104 (1.3%) to 220 (2.7%),
p< 0.0001. For both arms combined, the preintervention and postintervention rates were 210
(1.4%) and 386 (2.6%; p< 0.0001), respectively. The mean combined MMSE score for the
whole population in the year before the intervention was 21.5, and the year after was 22.1
(p = 0.38).
There was no difference between the intervention and the control group in the rate of peo-
ple referred without a cognitive disorder in the year after the intervention; 23 (0.3%) versus 35
(0.4%; p = 0.61), although this increased in both groups over time; intervention group (0.2% to
0.3%; p = 0.19); control group (0.1% to 0.4%; p< 0.0004).
All GPs were contacted, and no adverse events from the intervention were reported in rela-
tion to patient distress or difficulty with increased volume of work.
The costs of the leaflet were £2.16 per recipient, comprising £0.66 for producing the leaflet
(£198 per 300 leaflets); £1 per patient to identify patients on practice lists to send the leaflet to,
including identifying their postal address; and £0.50 for postage and packing costs.
Discussion
There was no between-group difference in our primary outcome, cognitive severity at diag-
nosis. Our intervention was designed to empower patients and increase early diagnosis of
dementia through increasing presentation to GPs with memory symptoms. The letters
resulted in more people presenting to their GPs from the intervention practices with sus-
pected memory problems. Although there was also a secular increase in GP referrals in both
groups, GPs in the intervention group referred less of the people who presented to them with
memory problems than in the nonintervention group. We do not know whether the extra
patients presenting but not referred were worried well or had cognitive deficits, but overall
in both groups there was no increase in the MMSE at diagnosis over time, so GPs are not
referring earlier.
While very low cost, this evidence-based complex intervention planned in accordance with
the Medical Research Council (MRC) complex intervention development recommendations
[20], and incorporating the identified elements of behaviour change of capability; opportunity;
and motivation for the patients [31], joins the list of unsuccessful interventions to change GP
behaviour and increase timely diagnosis. Previous interventions had not succeeded by trying
to work through GPs, we therefore adopted a new approach.
We are unable to be definitive as to why our approach was unsuccessful, but there are sev-
eral possible reasons. Our intervention helped empower patients with memory problems to
present to GPs. There was nothing specifically targeted at GPs to change their referral behav-
iour. The intervention may have encouraged some people who do not have dementia to attend
their GP and then be reassured their memory problem was not due to dementia, or receive
treatment for another problem. Neither GPs nor their patients reported the intervention was
upsetting or worrying or led to too much GP work. GPs may usually refer people at crisis
points or with more severe dementia, and both GPs and some memory clinics, despite national
policy, may not think referral is indicated in mild dementia. This seems to have been a pattern
in the past with high mortality in the year after diagnosis [32].
While the national strategy to increase dementia diagnosis has changed the behaviour of
GPs, no intervention trial has done so [3]. To our knowledge, this is the first analysis of
whether the change in policy also leads to an earlier diagnosis in terms of cognitive severity.
We find that it does not. Thus, GPs are referring more frequently but not earlier in the illness.
Encouraging prompt referral to memory clinics for diagnosis of dementia
PLOS Medicine | DOI:10.1371/journal.pmed.1002252 March 14, 2017 11 / 15
It is possible that patients in the intervention group, who presented to GPs and were not
referred, had a milder dementia or MCI.
Nonetheless, in the UK, an increase in diagnostic rates has followed the National Dementia
Strategy and the subsequent increase in memory clinics [33]. The Dementia Identification
Scheme, offering financial incentives to GPs for new diagnoses of dementia, started in October
2014 (https://www.england.nhs.uk/wp-content/uploads/2014/10/dementia-ident-schm-fin.
pdf) and coincided with the study period. National statistics about the people on dementia reg-
isters and our finding of highly significant increases in referral rates since the year before base-
line in both groups suggest the successful drivers of behaviour change were multifactorial and
likely to include national strategies (UK National Dementia Strategy and the Prime Minister’s
challenge on dementia) and societal change with an increase in publicity about dementia in
the national media, which can be considered as large and continuing interventions.
GPs do not refer all patients with suspected dementia to memory clinics, but our data
accounted for individual GPs’ previous referral practice. We did not expect the reduction in
using the MMSE as an initial measure of cognition and had to modify our primary outcome
measure. However, we successfully recruited to this study and there were enough people with
data on the combined MMSE, with more than twice as many new referrals in each group than
our initial power calculation required. We estimated missing MMSE scores by using the ACE
score and other covariates. We assumed that MMSE score can be calculated by the observed
covariates through our model and accounting for uncertainty in the estimation procedure
using multiple imputation. While this is more robust than relating the MMSE and ACE scores
using simple regression models to calculate point estimates, there may be unobserved factors,
potentially explaining absence in the main outcome variable. We assumed the ACE-R and
ACE111 were equivalent, as most of the questions are the same and they correlate significantly
(r = 0.99, p< 0.01). The ACE-III also continues to show high sensitivity and specificity at cut-
offs of the ACE-R [23]. We were, however, reassured that our other analyses produced similar
results to our primary analysis. We equated timely referral with earlier referral, but this may
not be so. The increase in diagnoses over time may mean more people were helped by an early
referral. We did not undertake a full economic evaluation of the intervention.
There was considerable missing data regarding ethnicity from the practices in Hertford-
shire, which are areas of around 85% white UK ethnicity for the whole population (http://
www.theguardian.com/news/datablog/2011/may/18/ethnic-population-england-wales#data,
accessed 23.6.16). The people in older age groups are probably even more predominantly of
white UK ethnicity. Only two people whose ethnicity was reported from these areas were spec-
ified as being of nonwhite UK origin. Thus, 68/84 (81.1%) of the people whom we did not
have ethnicity data came from these Hertfordshire areas. Our experience is that when an area’s
population is overwhelmingly white UK, practitioners do not judge it necessary to specify
those data in the notes. As other demographic data were detailed, this seems a likely explana-
tion. If we assumed that those whose data were missing from any practice were white UK eth-
nicity, then 140 (84.3%) people in the intervention and 160 (92.3%) in the control were white
UK, although this would probably be a slight overestimate.
While those who are forgetful are less likely to remember to respond to a letter, we were
looking for people with early illness, who do not have an all-pervasive memory problem. In
addition, the letter discussed whether they or another relative had a memory problem and
could have been picked up by partners or other relatives they were living with. More than half
the people referred lived with someone else.
We categorised the GP datasets through the coded data extracted using MIQUEST, but dif-
ferent GPs may record such data inconsistently, if at all. We were able to consider recording
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the year before the intervention and adjust for it. We therefore think the between-group differ-
ences are true differences.
Clinical implications and conclusions
An evidence-based complex intervention to empower patients with memory symptoms or
their families and increase early diagnosis of dementia through facilitating presentation to GPs
was unsuccessful. It increased those with suspected memory problems presenting to their GPs
but not referrals from there to memory services. We think this may be because GPs are con-
cerned about the availability of services, both in terms of waiting lists for diagnostic services
and of very limited postdiagnostic services.
We recruited from diverse areas and had excellent follow-up rates, so our findings of lack of
effectiveness are likely to be generalisable that GPs are not referring patients earlier in the ill-
ness. Interventions likely to be successful in decreasing cognitive severity at diagnosis will need
to target both the public and practitioners and particularly concentrate on the benefits of ear-
lier diagnosis.
Supporting information
S1 Text. Trial protocol.
(DOC)
S2 Text. CONSORT statement.
(DOC)
S3 Text. GP intervention leaflet.
(PDF)
S4 Text. GP intervention letter.
(PDF)
Acknowledgments
We would like to thank the National Institute for Health Research, through the Dementia and
Neurodegenerative Research Network (DeNDRoN), for approaching GP practices and the GP
practices and memory clinics who took part in this study; and NoClor (North Central London
Research Consortium), Central & East London PCRN (Primary Care Research Network), and
Herts & Essex PCRN for helping us identify the GP practices. We would like to thank the GPs’
surgeries; which were from inner and suburban London, Essex, and Hertfordshire (Camden,
Haringey, Barnet, Newham, Tower Hamlets, City and Hackney, Waltham Forest, Havering,
Redbridge, Barking and Dagenham, Herts Valley, and East and North Hertfordshire Clinical
Commissioning Groups). We would also like to thank Clare Goodman who chaired the steer-
ing committee, the Alzheimer’s Society monitors, Frank Arrojo, Sara Gregson, Jill Hodges,
and Dick Abbott and expert public involvement from Shirley Nurock of the Alzheimer’s Soci-
ety and from Age UK, Jeanne Franklin and Eula Harrison.
Moise Roche, Ritchard Ledgerd, Tom Freeth, Tara Harvey, Charlotte Stoner, Neelam Lax-
ham, Hannah Rollman, James Sinclair, and Kunle Ashaye collected and entered data from
memory clinics blind to allocation of GP practices. Filipa Ferreira and Jeremy van Vlymen
(University of Surrey) collected data using MIQUEST from GP practices and were also blind
to allocation. GL will act as guarantor.
Encouraging prompt referral to memory clinics for diagnosis of dementia
PLOS Medicine | DOI:10.1371/journal.pmed.1002252 March 14, 2017 13 / 15
Author Contributions
Conceptualization: GL GB SdL GR SM JH.
Data curation: GB SdL SP JH.
Formal analysis: GL GB SdL SP SM JH.
Funding acquisition: JH GL.
Investigation: GL AS JH.
Methodology: GL GB SdL SP JH.
Project administration: JH GL.
Resources: SdL.
Supervision: GL GB JH.
Writing – original draft: GL JH.
Writing – review & editing: GL GB AS SdL SP SM GR JH.
References
1. Prince M, Wimo A, Guerchet M, Ali G, Wu YT, Prina M. World Alzheimer Report 2015—The Global
Impact of Dementia: An analysis of prevalence, incidence, cost and trends. 2015. London, Alzheimer’s
Disease International (ADI).
2. Kosteniuk JG, Morgan DG, O’Connell ME, et al. Incidence and prevalence of dementia in linked admin-
istrative health data in Saskatchewan, Canada: a retrospective cohort study. BMC Geriatr 2015; 15:73.
doi: 10.1186/s12877-015-0075-3 PMID: 26135912
3. Mukadam N, Cooper C, Kherani N, Livingston G. A systematic review of interventions to detect demen-
tia or cognitive impairment. Int J Geriatr Psychiatry 2015; 30(1):32–45. doi: 10.1002/gps.4184 PMID:
25132209
4. Robinson L, Tang E, Taylor JP. Dementia: timely diagnosis and early intervention. BMJ 2015; 350:
h3029. doi: 10.1136/bmj.h3029 PMID: 26079686
5. Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Donepezil and memantine for
moderate-to-severe Alzheimer’s disease. N Engl J Med 2012; 366(10):893–903. doi: 10.1056/
NEJMoa1106668 PMID: 22397651
6. Livingston G, Kelly L, Lewis-Holmes E, Biao G, Morris S, Patel N, et al. Non-pharmacological interven-
tions for agitation in dementia: systematic review of randomised controlled trials. Br J Psychiatry 2014;
205(6):436–442. doi: 10.1192/bjp.bp.113.141119 PMID: 25452601
7. Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, King D, et al. Clinical effectiveness of a manual
based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health
of carers of family members with dementia: pragmatic randomised controlled trial. BMJ 2013; 347:
f6276. doi: 10.1136/bmj.f6276 PMID: 24162942
8. Banerjee S, Wittenberg R. Clinical and cost effectiveness of services for early diagnosis and interven-
tion in dementia. Int J Geriatr Psychiatry 2009; 24(7):748–754. doi: 10.1002/gps.2191 PMID:
19206079
9. Pinner G, Bouman WP. Attitudes of patients with mild dementia and their carers towards disclosure of
the diagnosis. Int Psychogeriatr 2003; 15(3):279–288. PMID: 14756163
10. Olafsdottir M, Foldevi M, Marcusson J. Dementia in primary care: why the low detection rate? Scand J
Prim Health Care 2001; 19(3):194–198. PMID: 11697565
11. Livingston G, Leavey G, Manela M, Livingston D, Rait G, Sampson E, et al. Making decisions for people
with dementia who lack capacity: qualitative study of family carers in UK. BMJ 2010; 341.
12. Department of Health. Living well with dementia: A National Dementia Strategy. 2009.
13. Bunn F, Goodman C, Sworn K, Rait G, Brayne C, Robinson L, et al. Psychosocial factors that shape
patient and carer experiences of dementia diagnosis and treatment: a systematic review of qualitative
studies. PLoS Med 2012; 9(10):e1001331. doi: 10.1371/journal.pmed.1001331 PMID: 23118618
Encouraging prompt referral to memory clinics for diagnosis of dementia
PLOS Medicine | DOI:10.1371/journal.pmed.1002252 March 14, 2017 14 / 15
14. Gove D, Downs M, Vernooij-Dassen M, Small N. Stigma and GPs’ perceptions of dementia. Aging Ment
Health 2015; 1–10.
15. Teel C, Carson P. Family experiences in the journey through dementia diagnosis and care. Journal of
Family Nursing 9[1], 38–58. 2011.
16. Werner P, Goldstein D, Karpas DS, Chan L, Lai C. Help-seeking for dementia: a systematic review of
the literature. Alzheimer Dis Assoc Disord 2014; 28(4):299–310. doi: 10.1097/WAD.
0000000000000065 PMID: 25321607
17. Robb K, Power E, Kralj-Hans I, et al. Flexible sigmoidoscopy screening for colorectal cancer: uptake in
a population-based pilot programme. J Med Screen 2010; 17(2):75–78. doi: 10.1258/jms.2010.010055
PMID: 20660435
18. Morbidity Information and Export Syntax (MIQUEST). 2016. NHS Digital. URL: http://systems.digital.
nhs.uk/data/miquest
19. Medical Research Council. Cluster randomised trials: Methodological and ethical considerations. 1–16.
2002. Medical Research Council. MRC clinical trials series.
20. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guid-
ance. Developing and evaluating complex interventions: the new Medical Research Council guidance.
BMJ. 2008 Sep 29; 337:a1655. doi: 10.1136/bmj.a1655 PMID: 18824488
21. Folstein MF, Folstein SE, Mchugh PR. Mini-Mental State—Practical Method for Grading Cognitive
State of Patients for Clinician. J Psychiatr Res 1975; 12(3):189–198 PMID: 1202204
22. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination
Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006;
21(11):1078–1085. doi: 10.1002/gps.1610 PMID: 16977673
23. Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s Cognitive Exami-
nation III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord 2013; 36
(3–4):242–250. doi: 10.1159/000351671 PMID: 23949210
24. Office National Statistics. Mid-year population estimates. 2010. Office for National Statistics; General
Register Office for Scotland; Northern Ireland Statistics and Research Agency.
25. Burback D, Molnar FJ, St JP, Man-Son-Hing M. Key methodological features of randomized controlled
trials of Alzheimer’s disease therapy. Minimal clinically important difference, sample size and trial dura-
tion. Dement Geriatr Cogn Disord 1999; 10(6):534–540.
26. Machin D, Campbell M, Tan S, Tan S. Sample Size Tables for Clinical Studies. Third ed. Wiley-Black-
well; 2009.
27. Newman JC, Feldman R. Copyright and open access at the bedside. N Engl J Med 2011; 365(26):2447–
2449. doi: 10.1056/NEJMp1110652 PMID: 22204721
28. Law E, Connelly PJ, Randall E, McNeill C, Fox HC, Parra MA, et al. Does the Addenbrooke’s Cognitive
Examination-revised add to the Mini-Mental State Examination in established Alzheimer disease?
Results from a national dementia research register. Int J Geriatr Psychiatry 2013; 28(4):351–355. doi:
10.1002/gps.3828 PMID: 22556006
29. Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R. Journal of
Statistical Software 2011; 45(3):1–67.
30. Rubin D. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.
31. Mitchie S, van Stralen M, West R. The behaviour change wheel: A new method for characterising and
designing behaviour change interventions. Implementation Science 2011; 6(42).
32. Rait G, Walters K, Bottomley C, Petersen I, Iliffe S, Nazareth I. Survival of people with clinical diagnosis
of dementia in primary care: cohort study. BMJ 2010; 341:c3584 doi: 10.1136/bmj.c3584 PMID:
20688840
33. Mukadam N, Livingston G, Rantell K, Rickman S. Diagnostic rates and treatment of dementia before
and after launch of a national dementia policy: an observational study using English national databases.
Bmj Open 2014; 4(1).
Encouraging prompt referral to memory clinics for diagnosis of dementia
PLOS Medicine | DOI:10.1371/journal.pmed.1002252 March 14, 2017 15 / 15
